Ergomed announces provision of clinical research services for COVID-19 clinical study
Ergomed CRO is a complete, global Phase I-IV clinical development and trial management service partner specialised in oncology and rare disease development
Orphan Drug Development
Therapeutic Area Expertise
In-house Phase I-IV Clinical Development
Unique Site & Physician Support Solutions
About Us
Investors
Careers
Contact Us
